Dalmeet Singh Chawla is a freelance science journalist based in London. His work has been featured in Nature, Science, Slate, Undark, The Economist, New Scientist and Pacific Standard, among other publications. See more about his work here: www.dalmeets.com.
Dalmeet Singh Chawla
Contributing writer
From this contributor
Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.
Faked results lead to retraction of high-profile cancer neuroscience study
By
Dalmeet Singh Chawla
18 June 2024 | 4 min read
‘Tainted kids,’ other odd phrases cropping up in autism studies
The “tortured phrases” — strangely worded paraphrases of established terms — may be the work of software that attempts to disguise plagiarism.
‘Tainted kids,’ other odd phrases cropping up in autism studies
By
Dalmeet Singh Chawla
2 May 2022 | 4 min read
Why was a study about autism cited by a paper on plant beauty?
Autism studies are appearing in the reference lists of entirely unrelated papers, suggesting what a few scholars worry is a plot to manipulate citations.
Why was a study about autism cited by a paper on plant beauty?
By
Dalmeet Singh Chawla
21 January 2022 | 5 min read
Large study supports discarding the term ‘high-functioning autism’
Autistic people described as ‘high functioning’ because they do not have intellectual disability often still struggle with daily living skills.
Large study supports discarding the term ‘high-functioning autism’
By
Dalmeet Singh Chawla
3 July 2019 | 3 min read
Data analysis, open access could improve peer-review process
Data analysis can improve the vetting of scientific papers, but first publishers must agree to make the information public.
Data analysis, open access could improve peer-review process
By
Dalmeet Singh Chawla, Undark
26 June 2019 | 7 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read